Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment

Table 4

Correlation among RANKL and RANKL/OPG ratio with markers of angiogenesis and disease activity (NS: not significant).

		OPG	HGF	LDH	VEGF	B2M	CRP	IL-6
RANKL	𝑟	NS	0.529	0.344	0.707	0.401	NS	0.422
	𝑃	NS	< 0.0001	< 0.01	< 0.0001	< 0.003	NS	< 0.001
RANKL/OPG	𝑟	−0.548	0.612	0.352	0.637	0.362	NS	0.390
	𝑃	< 0.0001	< 0.0001	< 0.009	< 0.0001	< 0.007	NS	< 0.004